Drugs that contain Emtricitabine; Rilpivirine Hydrochloride; Tenofovir Disoproxil Fumarate

1. List of Complera drug patents

COMPLERA's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8080551 GILEAD SCIENCES INC HIV inhibiting pyrimidines derivatives
Apr, 2023

(8 days from now)

US7125879 GILEAD SCIENCES INC HIV inhibiting pyrimidines derivatives
Apr, 2025

(2 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8101629 GILEAD SCIENCES INC Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
Aug, 2022

(7 months ago)

US8716264 GILEAD SCIENCES INC Compositions and methods for combination antiviral therapy
Jan, 2024

(9 months from now)

US9744181 GILEAD SCIENCES INC Compositions and methods for combination antiviral therapy
Jan, 2024

(9 months from now)

US8592397 GILEAD SCIENCES INC Compositions and methods for combination antiviral therapy
Jan, 2024

(9 months from now)

US9457036 GILEAD SCIENCES INC Compositions and methods for combination antiviral therapy
Jan, 2024

(9 months from now)

US8841310 GILEAD SCIENCES INC Combinations of a pyrimidine containing NNRTI with RT inhibitors
Dec, 2025

(2 years from now)

US10857102 GILEAD SCIENCES INC Therapeutic compositions comprising rilpivirine HCL and tenofovir disoproxil fumarate
Jan, 2033

(9 years from now)

Market Authorisation Date: 10 August, 2011

Treatment: Treatment of hiv infection

Dosage: TABLET;ORAL

How can I launch a generic of COMPLERA before it's patent expiration?
More Information on Dosage

COMPLERA family patents

49

United States

25

European Union

20

Norway

19

Japan

14

Australia

13

Hungary

12

China

11

Korea, Republic of

9

Croatia

8

Hong Kong

8

Argentina

8

Brazil

8

Spain

EA

8

EA

7

Denmark

7

Slovenia

7

Poland

7

Taiwan, Province of China

7

Canada

6

Israel

6

Mexico

6

Lithuania

AP

6

AP

6

Portugal

6

New Zealand

5

South Africa

5

Cyprus

5

Luxembourg

5

Ukraine

4

Austria

4

Singapore

3

Belgium

3

Costa Rica

3

Malaysia

3

Peru

2

Germany

2

RS

2

Ecuador

2

Nicaragua

2

ME

OA

1

OA

1

Egypt

1

Jordan

1

Morocco

1

Colombia

1

Netherlands

1

San Marino

1

Iceland

1

Chile

1

Panama

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic